---
schema_version: "secwatch.filing_event.v1"
accession: "0000929638-22-001839"
form_type: "8-K"
ticker: "MDIA"
cik: "0001784254"
company_name: "Mediaco Holding Inc."
filed_at: "2022-12-15T23:59:59+00:00"
generated_at: "2026-06-21T04:15:05.417286+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MediaCo cures Nasdaq stockholders' equity deficiency, delisting hearing cancelled

## Summary
- Received second Nasdaq letter on Dec 14, 2022 stating stockholders' equity deficiency ($2.5M minimum) has been cured.
- Previously disclosed Nov 15, 2022 deficiency letter; had requested hearing to present compliance plan.
- Scheduled hearing before Nasdaq Hearings Panel cancelled; Class A common stock (MDIA) continues listing on Nasdaq Capital Market.
- Company now in compliance with all applicable Nasdaq listing standards.

## SEC filing metadata
- accession: 0000929638-22-001839
- form_type: 8-K
- ticker: MDIA
- cik: 0001784254
- company_name: Mediaco Holding Inc.
- filed_at: 2022-12-15T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1784254/000092963822001839/0000929638-22-001839-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1784254/000092963822001839/a8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000929638-22-001839
- JSON: https://secwatch.observer/filing/0000929638-22-001839.json
- Plain text: https://secwatch.observer/filing/0000929638-22-001839.txt

## Key facts
- Listing & Compliance Notices
  Mediaco Holding Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: December 14, 2022, the Company received a letter (the “Second Nasdaq Letter”) from the Nasdaq Office of General Counsel stating that it had been informed the Staff that the Company’s stockholders’ equity deficiency had been cured, and that the Company is now in compliance with all applicable listing standards. Consequently, the Second Nasdaq Letter informed the Company that the scheduled hearing to appeal the delisting proceedings had been cancelled, and the Company’s stock will continue to be listed on The Nasdaq Stock Market. SIGNATURES Pursuant to the requirements of the Securities Exchan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1784254/000092963822001839/0000929638-22-001839-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.